MENU

XLO Xilio Therapeutics Forecast, Technical & Fundamental Analysis

Industry Biotechnology
XLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
XLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

XLO is expected to report earnings to rise 16.68% to -25 cents per share on February 26

Xilio Therapeutics XLO Stock Earnings Reports
Q4'24
Est.
$-0.26
Q3'24
Beat
by $0.03
Q2'24
Missed
by $0.01
Q1'24
Missed
by $0.51
Q4'23
Beat
by $0.07
The last earnings report on November 07 showed earnings per share of -21 cents, beating the estimate of -24 cents. With 133.64K shares outstanding, the current market capitalization sits at 40.76M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
828 Winter Street
Phone
+1 857 524-2466
Employees
73
Web
https://www.xiliotx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

XLO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, XLO has been loosely correlated with AVTX. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if XLO jumps, then AVTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XLO
1D Price
Change %
XLO100%
-3.19%
AVTX - XLO
35%
Loosely correlated
-0.42%
TPIA - XLO
25%
Poorly correlated
N/A
THAR - XLO
24%
Poorly correlated
+0.46%
VTGN - XLO
24%
Poorly correlated
-2.02%
GBIO - XLO
24%
Poorly correlated
-6.03%
More